Rigel Pharmaceuticals, Inc. (RIGL)
34.41
+0.26
(+0.76%)
USD |
NASDAQ |
Feb 09, 16:00
34.35
-0.06
(-0.17%)
After-Hours: 06:44
Rigel Pharmaceuticals EPS Diluted (Quarterly) : 1.456 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.875 |
| Ironwood Pharmaceuticals, Inc. | 0.2294 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Amicus Therapeutics, Inc. | 0.0558 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 27.90M |
| Revenue (Quarterly) | 69.46M |
| Total Expenses (Quarterly) | 41.56M |
| Enterprise Value | 548.32M |
| Gross Profit Margin (Quarterly) | 93.16% |
| Profit Margin (Quarterly) | 40.17% |
| Earnings Yield | 17.92% |
| Operating Earnings Yield | 18.82% |
| Normalized Earnings Yield | 17.92 |